GRI - GRI Bio, Inc.
1.33
0.120 9.023%
Share volume: 124,928
Last Updated: 04-11-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.14%
PREVIOUS CLOSE
CHG
CHG%
$1.21
0.12
0.10%
View ratios
| Fiscal Date | 12-31-2024 | |
|---|---|---|
| Fiscal Quarter | Q4 2024 | |
| Report Date | 03-14-2025 | |
| Total revenue | 0.000 | |
| Cost of revenue | 0.000 | |
| Gross profit | 0.000 | |
| Operating expenses | 1.953 M | |
| Selling general and admin | 1.125 M | |
| Research and development | 828.000 K | |
| Total expenses | 1.953 M | |
| Operating income | -1.953 M | |
| Ebit | -1.953 M | |
| Pretax income | -1.947 M | |
| Income tax | 0.000 | |
| Net income basic | 0.000 | |
| Net income | -1.947 M | |
